Skip to content

Dr. NJ HENDRICKX

Active
Private limited companyfounded 2017active for 8 yearsMechelsesteenweg 238a, 2550 Kontich, BelgiumKBO/BCE: BE 0684.561.068
Summary

Dr. NJ HENDRICKX has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,405 and a net result of €282,160. Equity has been shrinking by about 24% per year since 2018. Its solvency ranks better than 11% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 09-11-2017 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.269.856.814 2550 Kontich, since 09-11-2017
Financial year end
31 December
Peppol
Reachable since 08-02-2026

Board and ownership

Board
Shareholders
  • Niels-Jan Hendrickxannual accounts 2019

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€384,922
▼ 5.8%
Turnover
≈ €590,000
estimated
Profit
€282,160
▼ 8.1%
Equity
€20,405
=
Total assets
€374,029
▲ 8.8%
Filed on 28-04-2026, 94 days before the deadline
Score breakdownraises riskEquity €20,405 (5.5% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.96, cash €286,046Size: total assets €374,029Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 40% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 30-1
equity 5.5% of total assets
Liquidity 56+6
short-term debt 81.0% · cash 76.5%
Profitability 100=
return on assets 75.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026highest value 06-2026: < 0.1%● unchanged vs 05-2026highest value 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.96 (1.05 in 2024), below 1. Short-term debt is 81% and cash 76.5% of total assets. 94.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 11% of them on solvency, 31% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.96, cash €286,046
NBB · annual accounts
lowers risk · Size: total assets €374,029
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €20,405 (5.5% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-04-2026, 94 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
94 days early
2024
15 days early
2023
64 days early
2022
39 days early
2021
61 days early
2020
86 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 56 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 May (4 of the last 5 accounts filed within 33 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 89% of companies in human healthsector median 63.0% · 20,700 companies 5.5% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €282,160 8 years View

Recent changes

  1. · Gazette deed Change of role: HENDRICKX Niels-Jan Rudolf Floris, from manager and director to director
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Dr. NJ HENDRICKX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €329,000 and €404,000, founded between 2016 and 2018.

CompanyTotal assetsGross margin
Dr. NJ HENDRICKX Kontich€374,029€384,922
Dr. Daan DETROYER Nefrologie Zandhoven€363,630€416,633
Dr. PJH Vosselaar€329,940€365,266
ETRD Heist-op-den-Berg€329,312€362,192
Docteur Oléna Golub Elsene€385,190€367,832
DR. H. VERDOODT, ANESTHESIST Asse€346,677€376,992
dr. Vandenbussche Pieter, orthopedie Celles (lez-Tournai)€404,210€383,649
Full comparison

Key facts about Dr. NJ HENDRICKX

What is the company number of Dr. NJ HENDRICKX?
The company number of Dr. NJ HENDRICKX is 0684.561.068. The VAT number is the same number with BE in front: BE 0684.561.068.
Where is Dr. NJ HENDRICKX based?
The registered office is at Mechelsesteenweg 238a, 2550 Kontich.Company details
What does Dr. NJ HENDRICKX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. NJ HENDRICKX?
The legal form of Dr. NJ HENDRICKX is Private limited company (BV).
When was Dr. NJ HENDRICKX founded?
Dr. NJ HENDRICKX was founded on 09-11-2017.
Is Dr. NJ HENDRICKX still active?
Yes, Dr. NJ HENDRICKX is an active enterprise in the KBO register.
What is the turnover of Dr. NJ HENDRICKX?
The turnover in financial year 2025 is ≈ €590,000. This figure is estimated from the gross margin of €384,922 and 36 comparable companies (NACE 862). It probably lies between €530,000 and €750,000.Financials
Is Dr. NJ HENDRICKX profitable?
In financial year 2025, Dr. NJ HENDRICKX made a profit of €282,160.
Where can I find the annual accounts of Dr. NJ HENDRICKX?
Dr. NJ HENDRICKX filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. NJ HENDRICKX due?
Dr. NJ HENDRICKX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.